Ester-C (Pure).

Ascorbate converts ferric iron to the ferrous form the DMT1 transporter accepts and holds it away from phytate. It is the single strongest dietary enhancer of non-heme iron uptake.

Prolyl and lysyl hydroxylase both need ascorbate to keep their iron centre reduced, and those hydroxylations are what stabilise the collagen triple helix. Peptides supply residues, ascorbate lets the enzymes modify them.

Lysine residues in procollagen become hydroxylysine through an ascorbate dependent reaction, which is what allows crosslinking. The two are the classic connective tissue pairing.

Ascorbate donates an electron to the tocopheroxyl radical at the membrane surface, restoring active tocopherol. Water phase and lipid phase defences are linked through this step.

Glutathione reduces dehydroascorbate back to ascorbate while ascorbate spares glutathione from first contact with radicals. Each keeps the other usable.

Quercetin slows the oxidation of ascorbate in solution and ascorbate in turn reduces the quercetin radical after it acts. Bioflavonoid plus vitamin C is one of the oldest formulation pairings.

Zinc is a structural cofactor in hundreds of enzymes and transcription factors used by dividing immune cells, while ascorbate concentrates inside neutrophils and supports their normal oxidative chemistry. The routes are separate, which is why the two are combined so often.

Two steps in the pathway that builds carnitine from lysine and methionine are ascorbate dependent dioxygenase reactions. Carnitine synthesis therefore tracks ascorbate status.

Large ascorbate doses reduce copper to the cuprous state and lower its absorption and ceruloplasmin activity. Worth stating when a formula runs high ascorbate and low copper.

Prolyl 4-hydroxylase requires ascorbate to keep its active-site iron in the ferrous state, and without that the enzyme stalls after a few catalytic cycles. Proline is the substrate that enzyme acts on to make hydroxyproline, the residue that stabilises the collagen triple helix. Substrate and cofactor together is about as direct as a nutrient pairing gets.

Ascorbate protects reduced folate from oxidative degradation in solution and in the stomach, which is one reason the two travel together in food and in multivitamin premixes. The effect is on folate stability rather than on folate transport. Calcium ascorbate does the same job as any other ascorbate salt here, since the ascorbate anion is the active species.

Rutin and the related citrus flavonoids are routinely formulated alongside vitamin C on the basis that flavonoids and ascorbate regenerate each other's oxidised forms in solution. The redox chemistry is well described in vitro. Claims that flavonoids meaningfully raise ascorbate absorption in people are much weaker than the formulation habit suggests.

Proanthocyanidins and ascorbate sit in the same aqueous antioxidant network, with each capable of reducing the other's radical form. The pairing appears constantly in skin and vascular formulas for that reason. What has been measured is antioxidant capacity in assays, which is a marker and not an outcome.

Pine bark procyanidins are described as sparing ascorbate in vitro by taking over radical scavenging, which slows ascorbate consumption. Both compounds also feature in collagen-support formulas because ascorbate is the hydroxylase cofactor. The interaction is chemical and demonstrated in assays rather than clinical endpoints.

Dihydrolipoic acid reduces dehydroascorbate back to ascorbate, one of the documented arms of the cellular antioxidant recycling network alongside glutathione. That places lipoic acid upstream of ascorbate regeneration rather than in competition with it. The chemistry is settled; how much difference it makes to ascorbate status at supplement doses is not.

Astaxanthin sits in the lipid phase of membranes while ascorbate works in the aqueous phase, so the two cover different compartments. Ascorbate can regenerate lipid-phase antioxidants at the membrane surface, which is the same relationship it has with vitamin E. Compartment coverage is the rationale, not any measured additive outcome.

Dopamine beta-hydroxylase uses ascorbate as its electron donor to convert dopamine to noradrenaline, and tyrosine is the dietary precursor feeding that chain. This is a textbook cofactor relationship in catecholamine biosynthesis. It describes a normal biosynthetic route and says nothing about mood or performance.

High concentrations of ascorbate degrade cobalamin in solution, which is why premix formulators separate the two or protect the B12 with a coating. Whether the same happens to a meaningful degree in the gut after ordinary doses has been argued both ways since the 1970s. The stability issue in the bottle is real regardless of the physiological question.

Calcium ascorbate contributes elemental calcium, roughly a tenth of the salt by weight, so a gram-level vitamin C dose brings calcium with it. Someone already taking calcium carbonate needs to add that to the total rather than ignore it. Nothing here is a problem at ordinary doses, it is arithmetic that belongs on the label.

The point of calcium ascorbate is that neutralising ascorbic acid gives a near-neutral pH preparation for people who find the free acid harsh. Taking it alongside betaine hydrochloride, which is added specifically to lower gastric pH, works against that design. The two are not chemically incompatible, they simply pull in opposite directions.

N-acetylcysteine feeds glutathione synthesis, and glutathione is one of the main routes for reducing dehydroascorbate back to ascorbate. Ascorbate returns the favour by helping keep glutathione reduced. The two sit in one recycling loop rather than acting independently.

Selenium is required for glutathione peroxidases, which work in the same antioxidant network ascorbate supports. Separately, high-dose ascorbate can reduce selenite to elemental selenium in the gut lumen and lower its absorption, which is why the selenite form and large vitamin C doses are usually spaced apart. Selenomethionine and selenium yeast do not show that interaction.

Hyaluronic acid and collagen are both structural components of the dermal matrix, and ascorbate is the required cofactor for the hydroxylases that build collagen. Combining them targets two different parts of the same matrix. Skin measures in this space are usually instrument readings rather than clinical outcomes.

Ascorbate reduces the tocopheroxyl and tocotrienoxyl radicals at the membrane surface, returning the vitamin E family compound to its active form. Tocotrienols carry the same chromanol head as tocopherol and behave the same way in that step. A systematic review of tocotrienol trials names vitamin C among the co-administered nutrients, which is co-supplementation rather than a tested pairing.

Carotenoids operate in the lipid phase and ascorbate in the aqueous phase, so the pair covers both compartments and ascorbate can help regenerate carotenoid radicals at the interface. Mixed antioxidant preparations are built on this compartment logic. The evidence is chemical, and antioxidant capacity assays are markers.